Global 10-DAB III Market - Industry Analysis Size Share Growth Trends and Forecast 2024 - 2031

Product Description

10-Deacetylbaccatin III is an inhibitor of microtubule assembly (IC50s = 23 and 0.9 µM for porcine brain and Physaram microtubules, respectively) found in T. baccata extracts. It is a precursor in the semisynthetic synthesis of paclitaxel (Item No. 10461) and other semisynthetic toxoids.10-Deacetylbaccatin III also selectively inhibits growth of L. donovani intracellular amastigotes within J774 murine macrophages (IC50 = 70 nM), while having no effect on macrophage morphology. The 10-DAB III market revenue was xx Million USD in 2019, grew to xx Million USD in 2023, and will reach xx Million USD in 2031, with a CAGR of xx during 2024-2031. Considering the influence of COVID-19 on the global 10-DAB III market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions. This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery. Under COVID-19 Outbreak, how the 10-DAB III Industry will develop is also analyzed in detail in Chapter 1.8 of this report. Major Players in 10-DAB III market are: Ambe Phytoextracts Pvt Ltd Aphios Sarv Biolabs Pvt Hainan Yew Pharmaceutical SM Herbals Yuannan Hande Sai Phytoceuticals Alchem International South Pharmaceutical HAOXUAN Indena Most important types of 10-DAB III products covered in this report are: 97% 98% 99% Others Most widely used downstream fields of 10-DAB III market covered in this report are: Pharmaceutical Biotechnology Major Regions or countries covered in this report: North America Europe China Japan Middle East and Africa South America India South Korea Southeast Asia Others In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations. In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out. In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.